| P2093 | author name string | S A Rosenberg | |
| | N P Restifo | |
| | T Z Zaks | |
| | D B Chappell | |
| P2860 | cites work | Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis | Q24647389 |
| | Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity | Q24680778 |
| | Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor | Q36080342 |
| | Expression of Fas ligand in liver metastases of human colonic adenocarcinomas | Q36186304 |
| | Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death | Q36367540 |
| | Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli | Q36377464 |
| | T cell receptor signals enhance susceptibility to Fas-mediated apoptosis | Q36380957 |
| | Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity | Q36400613 |
| | Human melanoma cells do not express Fas (Apo-1/CD95) ligand | Q36454464 |
| | Human lung carcinomas express Fas ligand. | Q41120854 |
| | Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells | Q41142242 |
| | Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. | Q41284156 |
| | Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 |
| | The molecular regulation of lymphocyte apoptosis | Q41433490 |
| | The role of the Caspase family of cysteine proteases in apoptosis | Q41433521 |
| | Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy | Q41734221 |
| | Caspase activity is required for commitment to Fas-mediated apoptosis. | Q42623004 |
| | Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 |
| | Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis | Q43539775 |
| | Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials | Q44098509 |
| | Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 |
| | Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. | Q47757272 |
| | Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 |
| | Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3 | Q59156995 |
| | Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape | Q71762882 |
| | Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 | Q72052802 |
| | Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression | Q72133139 |
| | Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response | Q72359898 |
| | Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases | Q73103920 |
| | Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies | Q74515314 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | suicide | Q10737 |
| P304 | page(s) | 3273-3279 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition | |
| P478 | volume | 162 | |